Applied DNA Sciences Gets a Buy Rating from Maxim Group

In a report released today, Brian Kinstlinger from Maxim Group reiterated a Buy rating on Applied DNA Sciences (NASDAQ: APDN), with a price target of $5. The company’s shares closed yesterday at $1.54.

Kinstlinger wrote:

“APDN has granted Colorcon exclusive worldwide rights to use its molecular tags and other supply chain authentication technologies in film coatings for solid oral dosage applications.”

According to, Kinstlinger is a 1-star analyst with an average return of -0.7% and a 49.7% success rate. Kinstlinger covers the Technology sector, focusing on stocks such as Helios & Matheson North America Inc, BIO-key International Inc, and Caci International.

Applied DNA Sciences has an analyst consensus of Moderate Buy, with a price target consensus of $5.

Based on Applied DNA Sciences’ latest earnings report for the quarter ending December 31, the company posted quarterly revenue of $647.7K and GAAP net loss of $3.18 million. In comparison, last year the company earned revenue of $905.4K and had a GAAP net loss of $3.43 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Applied DNA Sciences, Inc. engages in the security solutions. It provides biotechnology-driven solutions to help protect products, brands, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion.

Leave a Reply

Your email address will not be published. Required fields are marked *